Kaleigh Bulloch Whitehall

Pegvaliase for the treatment of phenylketonuria: Final results of a long-term phase 3 clinical trial program

Cary O. Harding, Nicola Longo, Hope Northrup et al. · Molecular Genetics and Metabolism Reports · 2024 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Long-term preservation of intellectual functioning in sapropterin-treated infants and young children with phenylketonuria: A seven-year analysis

Susan E. Waisbren, Barbara K. Burton, Annette Feigenbaum et al. · Molecular Genetics and Metabolism · 2021 · 16 citations · Full text

Education, Child Health, Pediatrics +12

Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics

Darius J. Adams, Hans C. Andersson, Heather Bausell et al. · Molecular Genetics and Metabolism Reports · 2021 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data

Fran Rohr, Barbara K. Burton, Anne Dee et al. · Molecular Genetics and Metabolism · 2023 · 15 citations

Agriculture, Pharmacology, Pharmacotherapy +17

Real-world treatment, dosing, and discontinuation patterns among patients treated with pegvaliase for phenylketonuria: Evidence from dispensing data

Melissa Lah, Keziah Cook, Aparna Gomes et al. · Molecular Genetics and Metabolism Reports · 2022 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +3